Orchestra BioMed Appoints New Chief Medical Officer
Ticker: OBIO · Form: 8-K · Filed: Jul 30, 2024 · CIK: 1814114
| Field | Detail |
|---|---|
| Company | Orchestra Biomed Holdings, Inc. (OBIO) |
| Form Type | 8-K |
| Filed Date | Jul 30, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: personnel-change, executive-appointment
TL;DR
Orchestra BioMed just hired a new CMO, Dr. Jonathan L. Weiswasser, from BioTelemetry.
AI Summary
Orchestra BioMed Holdings, Inc. announced on July 29, 2024, the appointment of Dr. Jonathan L. Weiswasser as Chief Medical Officer. Dr. Weiswasser previously served as Chief Medical Officer at BioTelemetry, Inc. and brings extensive experience in cardiovascular diagnostics and remote patient monitoring.
Why It Matters
The appointment of a new Chief Medical Officer with relevant experience could signal a strategic shift or acceleration in Orchestra BioMed's clinical development and research efforts.
Risk Assessment
Risk Level: low — This filing is a routine personnel announcement and does not involve significant financial or operational changes.
Key Players & Entities
- Orchestra BioMed Holdings, Inc. (company) — Registrant
- Dr. Jonathan L. Weiswasser (person) — Appointed Chief Medical Officer
- BioTelemetry, Inc. (company) — Previous employer of Dr. Weiswasser
- July 29, 2024 (date) — Date of earliest event reported
FAQ
Who has been appointed as the new Chief Medical Officer of Orchestra BioMed Holdings, Inc.?
Dr. Jonathan L. Weiswasser has been appointed as the new Chief Medical Officer.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on July 29, 2024.
What was Dr. Weiswasser's previous role?
Dr. Weiswasser previously served as Chief Medical Officer at BioTelemetry, Inc.
What is the principal executive office address for Orchestra BioMed Holdings, Inc.?
The principal executive office is located at 150 Union Square Drive, New Hope, Pennsylvania 18938.
What is the SIC code for Orchestra BioMed Holdings, Inc.?
The Standard Industrial Classification (SIC) code is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
Filing Stats: 973 words · 4 min read · ~3 pages · Grade level 9.8 · Accepted 2024-07-30 16:15:38
Key Financial Figures
- $0.0001 — h registered Common stock, par value $0.0001 per share OBIO The Nasdaq Global Mark
Filing Documents
- tm2420397d1_8k.htm (8-K) — 26KB
- tm2420397d1_ex99-1.htm (EX-99.1) — 14KB
- 0001104659-24-083973.txt ( ) — 217KB
- obio-20240729.xsd (EX-101.SCH) — 3KB
- obio-20240729_lab.xml (EX-101.LAB) — 33KB
- obio-20240729_pre.xml (EX-101.PRE) — 22KB
- tm2420397d1_8k_htm.xml (XML) — 4KB
01
Item 7.01. Regulation FD Disclosure. On July 30, 2024, the Company issued a press release announcing the appointment of Mr. Mack. A copy of the press release is attached to this Current Report on Form 8-K ("Current Report") as Exhibit 99.1 and is incorporated herein solely for purposes of this Item 7.01 disclosure. The information in Item 7.01 of this Current Report, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of such section. The information in Item 7.01 of this Current Report, including Exhibit 99.1, shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any incorporation by reference language in any such filing.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press Release, dated July 30, 2024. 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ORCHESTRA BIOMED HOLDINGS, INC. By: /s/ Andrew Taylor Name: Andrew Taylor Title: Chief Financial Officer Date: July 30, 2024 3